Secondary Logo

Journal Logo

Erratum

Efficacy and Safety of Intravitreal Aflibercept Using a Treat-and-Extend Regimen For Neovascular Age-Related Macular Degeneration—The Aries Study: A Randomized Clinical Trial—Erratum

doi: 10.1097/IAE.0000000000003560
  • Free

In the September 2021 issue of Retina, the Journal of Retinal and Vitreous Diseases, in the article by Mitchell et al,1 “Efficacy and Safety of Intravitreal Aflibercept Using a Treat-and-Extend Regimen for Neovascular Age-Related Macular Degeneration—The ARIES Study: A Randomized Clinical Trial,” the links to the Supplemental Digital Content are incorrect. The correct link for Supplement Digital Contents file 1 is https://links.lww.com/IAE/B691, and the correct link for Supplemental Digital Contents file 2 is https://links.lww.com/IAE/B692.

Reference

1. Mitchell P, Holz FG, Hykin P, et al. Efficacy and safety of intravitreal Aflibercept using a treat-and-extend regimen for neovascular age-related macular degeneration: the ARIES study: a randomized clinical trial. Retina 2021:1911–1920.

Supplemental Digital Content